GERON CORP Interest and Other Income
GERON CORP (GERN) reported Interest and Other Income of $504.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2020-11-05
- GERON CORP interest and other income for the quarter ending 2020-09-30 was $504.00K, a 50.64% decline year-over-year.
- GERON CORP interest and other income for the quarter ending 2020-06-30 was $475.00K, a 57.32% decline year-over-year.
- GERON CORP interest and other income for the quarter ending 2020-03-31 was $754.00K, a 35.11% decline year-over-year.
- GERON CORP interest and other income for the quarter ending 2019-12-31 was $925.00K, a 17.41% decline year-over-year.
- GERON CORP interest and other income for fiscal 2019 was $4.22M, a 28.26% increase from fiscal 2018.
- GERON CORP interest and other income for fiscal 2018 was $3.29M, a 132.42% increase from fiscal 2017.
- GERON CORP interest and other income for fiscal 2017 was $1.42M, a 18.79% increase from fiscal 2016.
- GERON CORP interest and other income for fiscal 2016 was $1.19M, a 76.07% increase from fiscal 2015.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2020-09-30 | $504.00K 10-Q · filed 2020-11-05 | $979.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.73M 10-Q · filed 2020-11-05 | $2.66M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | $475.00K 10-Q · filed 2020-08-06 | $1.23M 10-Q · filed 2020-08-06 | $2.15M derived: sum of 3 quarters · filed 2020-08-06 | $3.17M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-03-31 | $754.00K 10-Q · filed 2020-05-28 | $1.68M derived: sum of 2 quarters · filed 2020-05-28 | $2.70M derived: sum of 3 quarters · filed 2020-11-05 | $3.81M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-12-31 | $925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.95M derived: sum of 2 quarters · filed 2020-11-05 | $3.06M derived: sum of 3 quarters · filed 2020-11-05 | $4.22M 10-K · filed 2020-03-12 |
| 2019-09-30 | $1.02M 10-Q · filed 2020-11-05 | $2.13M derived: sum of 2 quarters · filed 2020-11-05 | $3.30M 10-Q · filed 2020-11-05 | $4.42M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.11M 10-Q · filed 2020-08-06 | $2.27M 10-Q · filed 2020-08-06 | $3.40M derived: sum of 3 quarters · filed 2020-08-06 | $4.46M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $1.16M 10-Q · filed 2020-05-28 | $2.28M derived: sum of 2 quarters · filed 2020-05-28 | $3.34M derived: sum of 3 quarters · filed 2020-05-28 | $4.06M derived: sum of 4 quarters · filed 2020-05-28 |
| 2018-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.18M derived: sum of 2 quarters · filed 2020-03-12 | $2.90M derived: sum of 3 quarters · filed 2020-03-12 | $3.29M 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.06M 10-Q · filed 2019-11-06 | $1.78M derived: sum of 2 quarters · filed 2019-11-06 | $2.17M 10-Q · filed 2019-11-06 | $2.55M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $717.00K 10-Q · filed 2019-08-01 | $1.11M 10-Q · filed 2019-08-01 | $1.49M derived: sum of 3 quarters · filed 2020-03-12 | $1.85M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $394.00K 10-Q · filed 2019-05-02 | $769.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.13M derived: sum of 3 quarters · filed 2020-03-12 | $1.48M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $738.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.08M derived: sum of 3 quarters · filed 2020-03-12 | $1.42M 10-K · filed 2020-03-12 |
| 2017-09-30 | $363.00K 10-Q · filed 2018-11-01 | $709.00K derived: sum of 2 quarters · filed 2018-11-01 | $1.04M 10-Q · filed 2018-11-01 | $1.36M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $346.00K 10-Q · filed 2018-07-31 | $678.00K 10-Q · filed 2018-07-31 | $999.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.32M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $332.00K 10-Q · filed 2018-05-10 | $653.00K derived: sum of 2 quarters · filed 2019-03-07 | $975.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.27M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $643.00K derived: sum of 2 quarters · filed 2019-03-07 | $936.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.19M 10-K · filed 2019-03-07 |
| 2016-09-30 | $322.00K 10-Q · filed 2017-11-01 | $615.00K derived: sum of 2 quarters · filed 2017-11-01 | $871.00K 10-Q · filed 2017-11-01 | $1.07M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $293.00K 10-Q · filed 2017-08-09 | $549.00K 10-Q · filed 2017-08-09 | $745.00K derived: sum of 3 quarters · filed 2018-03-16 | $932.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $256.00K 10-Q · filed 2017-05-09 | $452.00K derived: sum of 2 quarters · filed 2018-03-16 | $639.00K derived: sum of 3 quarters · filed 2018-03-16 | $784.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $383.00K derived: sum of 2 quarters · filed 2018-03-16 | $528.00K derived: sum of 3 quarters · filed 2018-03-16 | $677.00K 10-K · filed 2018-03-16 |
| 2015-09-30 | $187.00K 10-Q · filed 2016-11-03 | $332.00K derived: sum of 2 quarters · filed 2016-11-03 | $481.00K 10-Q · filed 2016-11-03 | $581.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $145.00K 10-Q · filed 2016-08-03 | $294.00K 10-Q · filed 2016-08-03 | $394.00K derived: sum of 3 quarters · filed 2017-03-01 | $485.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $149.00K 10-Q · filed 2016-05-05 | $249.00K derived: sum of 2 quarters · filed 2017-03-01 | $340.00K derived: sum of 3 quarters · filed 2017-03-01 | $439.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $191.00K derived: sum of 2 quarters · filed 2017-03-01 | $290.00K derived: sum of 3 quarters · filed 2017-03-01 | $373.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $91.00K 10-Q · filed 2015-11-05 | $190.00K derived: sum of 2 quarters · filed 2015-11-05 | $273.00K 10-Q · filed 2015-11-05 | $388.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $99.00K 10-Q · filed 2015-08-05 | $182.00K 10-Q · filed 2015-08-05 | $297.00K derived: sum of 3 quarters · filed 2016-03-10 | $996.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $83.00K 10-Q · filed 2015-05-07 | $198.00K derived: sum of 2 quarters · filed 2016-03-10 | $897.00K derived: sum of 3 quarters · filed 2016-03-10 | $953.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $814.00K derived: sum of 2 quarters · filed 2016-03-10 | $870.00K derived: sum of 3 quarters · filed 2016-03-10 | $951.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | $699.00K 10-Q · filed 2014-11-05 | $755.00K derived: sum of 2 quarters · filed 2014-11-05 | $836.00K 10-Q · filed 2014-11-05 | $3.45M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-06-30 | $56.00K 10-Q · filed 2014-08-11 | $137.00K 10-Q · filed 2014-08-11 | $2.75M derived: sum of 3 quarters · filed 2015-03-11 | $2.89M derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-03-31 | $81.00K 10-Q · filed 2014-05-01 | $2.70M derived: sum of 2 quarters · filed 2015-03-11 | $2.84M derived: sum of 3 quarters · filed 2015-03-11 | $3.00M derived: sum of 4 quarters · filed 2015-03-11 |
| 2012-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $2.76M derived: sum of 2 quarters · filed 2015-03-11 | $2.92M derived: sum of 3 quarters · filed 2015-03-11 | $3.10M 10-K · filed 2015-03-11 |
| 2012-09-30 | $140.00K 10-Q · filed 2013-11-07 | $305.00K derived: sum of 2 quarters · filed 2013-11-07 | $481.00K 10-Q · filed 2013-11-07 | $685.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $165.00K 10-Q · filed 2013-08-08 | $341.00K 10-Q · filed 2013-08-08 | $545.00K derived: sum of 3 quarters · filed 2014-03-17 | $782.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $176.00K 10-Q · filed 2013-05-03 | $380.00K derived: sum of 2 quarters · filed 2014-03-17 | $617.00K derived: sum of 3 quarters · filed 2014-03-17 | $904.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $441.00K derived: sum of 2 quarters · filed 2014-03-17 | $728.00K derived: sum of 3 quarters · filed 2014-03-17 | $1.02M 10-K · filed 2014-03-17 |
| 2011-09-30 | $237.00K 10-Q · filed 2012-11-02 | $524.00K derived: sum of 2 quarters · filed 2012-11-02 | $820.00K 10-Q · filed 2012-11-02 | $2.25M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $287.00K 10-Q · filed 2012-08-03 | $583.00K 10-Q · filed 2012-08-03 | $2.01M derived: sum of 3 quarters · filed 2013-03-15 | $2.23M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $296.00K 10-Q · filed 2012-05-07 | $1.72M derived: sum of 2 quarters · filed 2013-03-15 | $1.95M derived: sum of 3 quarters · filed 2013-03-15 | $2.14M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.65M derived: sum of 2 quarters · filed 2013-03-15 | $1.84M derived: sum of 3 quarters · filed 2013-03-15 | $2.04M 10-K · filed 2013-03-15 |
| 2010-09-30 | $223.00K 10-Q · filed 2011-11-03 | $417.00K derived: sum of 2 quarters · filed 2011-11-03 | $619.00K 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $194.00K 10-Q · filed 2011-08-05 | $396.00K 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $1.37M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |